AstraZeneca sells Crohn's disease drug for $380M By: Philadelphia Business Journal via Business Journals November 23, 2015 at 09:39 AM EST AstraZeneca entered into an agreement Monday to sell the U.S rights to its Crohn’s disease Entocort to Perrigo Co... Read More >>
